In June, Hina revealed her stage 3 breast cancer diagnosis Hina Khan recently shared on Instagram that she has been diagnosed with mucositis, a side effect of her chemotherapy treatment for stage 3 ...

Oropharyngeal mucositis is an acute and distressing toxic effect of chemotherapy and head and neck irradiation. This oral sequela significantly impairs the daily functioning and quality of life of ...

Causes of mucositis: Chemotherapy, radiation therapy, and immunotherapy are leading causes of mucositis, the condition actress Hina Khan is diagnosed with (Image ...

Researchers worldwide believe low-dose light therapy may replace opioids in treating oral mucositis, a common side effect of certain cancer treatments. Low-dose light therapy may help prevent oral ...

Phase 3 clinical trial results showed that certain mouthwashes benefit and reduce pain in patients with oral mucositis. Patients and health care providers don’t have a problem with understanding oral ...

Breast cancer is the leading cancer among Indian women, especially in urban regions due to lifestyle shifts. Early detection challenges contribute to lower survival rates. Essential measures include ...

Radiation therapy remains the primary method of treatment for patients with head and neck cancer. The tissue destruction and functional alterations in the oral cavity lead to the development of oral ...

Oral mucositis is a complication of high-dose chemotherapy and radiotherapy and has no effective standard treatment. It may have serious sequelae, including pain requiring opioid analgesia, inadequate ...

Please provide your email address to receive an email when new articles are posted on . An 8-year-old boy presented to the ED with a fever and a painful rash involving his mouth, eyes and genitals. He ...

A 43-year-old Caucasian man with a medical history of hypertension was transferred to Lahey Hospital and Medical Center from an outside hospital with a 2-week history of bilateral red eye, fevers, ...

Last Friday, Soligenix (OTC BB:SNGX) held an analyst moderated conference with investors to discuss the potential of its lead candidate SGX942 for oral mucositis (OM) Experts and management who ...